ES2127133B1 - USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE. - Google Patents
USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE.Info
- Publication number
- ES2127133B1 ES2127133B1 ES9700827A ES9700827A ES2127133B1 ES 2127133 B1 ES2127133 B1 ES 2127133B1 ES 9700827 A ES9700827 A ES 9700827A ES 9700827 A ES9700827 A ES 9700827A ES 2127133 B1 ES2127133 B1 ES 2127133B1
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- manufacture
- prevention
- treatment
- dihydroxybenzenosphone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
Utilización de derivados 2,5-dihidroxibencenosulfónicos para la fabricación de medicamentos destinados al tratamiento y a la prevención de la enfermedad de Alzheimer. Utilización de derivados 2,5-dihidroxibencenosulfónicos de fórmula general I, en la cual: R representa H o SO{sup,- {sub,3 ; B representa Ca{sup,++ o H{sub,2 N{sup,+ (C{sub,2 H{sub,5 ){sub,2 ; n representa 1 ó 2; y m representa 1 ó 2, para la fabricación de medicamentos destinados a prevenir la formación de la proteína amiloide asociada a la enfermedad de Alzheimer.Use of 2,5-dihydroxybenzenesulfonic derivatives for the manufacture of drugs for the treatment and prevention of Alzheimer's disease. Use of 2,5-dihydroxybenzenesulfonic derivatives of general formula I, in which: R represents H or SO {sup, - {sub, 3; B represents Ca {sup, ++ or H {sub, 2 N {sup, + (C {sub, 2 H {sub, 5) {sub, 2; n represents 1 or 2; and m represents 1 or 2, for the manufacture of drugs intended to prevent the formation of the amyloid protein associated with Alzheimer's disease.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604181 | 1996-04-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2127133A1 ES2127133A1 (en) | 1999-04-01 |
ES2127133B1 true ES2127133B1 (en) | 1999-12-01 |
Family
ID=9490864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9700827A Expired - Fee Related ES2127133B1 (en) | 1996-04-03 | 1997-04-03 | USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2127133B1 (en) |
-
1997
- 1997-04-03 ES ES9700827A patent/ES2127133B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2127133A1 (en) | 1999-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68916693T2 (en) | Molecular diagnosis of Alzheimer's disease. | |
ES2170104T3 (en) | INHIBITORS OF THE PRODUCTION OF BETA-AMILOID PROTEINS. | |
HUP9700603A1 (en) | Pharmaceutical preparation for the treatment of blood coagulation disorders | |
DK1056856T3 (en) | Modified ciliary neurotrophic factor and methods for its formation and use | |
DK678887D0 (en) | PHARMACEUTICAL PREPARATIONS | |
DE3679920D1 (en) | SPIRO-3-HETEROAZOLIDINE COMPOUNDS AND THEIR SALTS, THEIR PRODUCTION AND THE PHARMACEUTICAL AGENTS CONTAINING THEM. | |
ATE162075T1 (en) | COMBINATION PHARMACEUTICAL PREPARATION CONTAINING A URICOSURIC AGENT AND AN EXCITATORY AMINO ACID ANTAGONIST | |
IT8322855A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE. | |
PT998287E (en) | USES OF LEVOBUPIVACAINE | |
DE69201660D1 (en) | Use of acetyl L-carnitine for the therapeutic treatment of coma. | |
TR200000455T2 (en) | The use of fanquinone in the treatment of Alzheimer's disease. | |
IT8721115A0 (en) | PHYTO-PREPARATION FOR THE TREATMENT OF SKIN DISEASES. | |
DE69621786T2 (en) | AMINOTETRAL IN DERIVATIVE FOR THE TREATMENT OF HEART CIRCULAR DISEASE | |
ES2127133B1 (en) | USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE. | |
DE3380923D1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS. | |
NO971453D0 (en) | Use of bradykinin antagonists in the manufacture of drugs for the treatment of chronic fibrogenetic and acute liver diseases | |
LV11524A (en) | Use of benzidamine as a treatment for pathological conditions induced by TNF | |
HUP0102116A2 (en) | Paroxetine ascorbate, process for its preparation and its pharmaceutical use | |
SE8802323D0 (en) | 8ALFA-ACYLAMINOERGOLINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
IT8919216A0 (en) | DEVICE FOR THE SURGICAL TREATMENT OF ASTIGMATISM. | |
DE68914886T2 (en) | Agent for the treatment of Raynaud's disease. | |
IT9048106A0 (en) | MEDICINAL ASSOCIATION FOR THE TREATMENT OF HYPERTENSION AND CONGESTIVE HEART FAILURE. (CASE 100-7516) | |
RU98103406A (en) | METHOD FOR TREATING VIBRATIONAL DISEASE | |
ITMI20022594A1 (en) | THERAPEUTIC COMBINATION FOR THE TREATMENT OF HYPERTENSION. | |
RU95122486A (en) | MEANS FOR TREATMENT OF TICHOUS HYPERKINESIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19990401 Kind code of ref document: A1 Effective date: 19990401 |
|
FD1A | Patent lapsed |
Effective date: 20020401 |